| Condition | Intervention and criteria |
| Heart failure53 | ACEI or ARB for discharge if patient has documented or suspected left ventricular ejection fraction <40% or systolic heart failure |
| Bisoprolol, carvedilol or metoprolol for discharge if patient has documented or suspected left ventricular ejection fraction <40% or systolic heart failure | |
| Spironolactone for discharge if patient has documented or suspected left ventricular ejection fraction <40% or systolic heart failure with NYHA Class III/IV symptoms | |
| Salt restriction in-hospital orders or counselling if patient has documented or suspected left ventricular ejection fraction <40% or systolic heart failure with current or prior symptoms of heart failure with evidence of current fluid retention | |
| Coronary artery disease54 | Aspirin for discharge if patient has angiographic evidence of angina, history of myocardial infarction or documentation of coronary artery disease |
| Ramipril for discharge if patient has angiographic evidence of angina, history of myocardial infarction or documentation of coronary artery disease | |
| Beta blocker for discharge if patient has angiographic evidence of angina, history of myocardial infarction or documentation of coronary artery disease | |
| Statin for discharge if patient has angiographic evidence of angina, history of myocardial infarction or documentation of coronary artery disease | |
| Ischaemic stroke55 | Aspirin for discharge if patient has a history of transient ischaemic attacks or ischaemic stroke |
| Atrial fibrillation56 | Warfarin for discharge if patient has chronic or paroxysmal atrial fibrillation with CHADS2 score ⩾1 |
| Type II diabetes57 | Aspirin for discharge if patient has type II diabetes with age >40 years |
| Statins for discharge if patient has type II diabetes with age >40 years | |
| Ramipril for discharge if patient has type II diabetes with any of the following cardiovascular risk factors: age >55 years, coronary artery disease, stroke, dyslipidaemia, microalbuminuria, or smoking | |
| ACEI or ARB for discharge if patient has type II diabetes with hypertension with microalbuminuria documented or ACR 2.0–20.0 mg/mmol (male) and 2.8–28.0 mg/mmol (female) | |
| ARB for discharge if patient has type II diabetes with hypertension with macroalbuminuria documented or ACR >20.0 mg/mmol (male) and >28.0 mg/mmol (female) | |
| Osteoporosis58 | Bisphosphonate and calcium and vitamin D for discharge or bisphosphonate for discharge with documentation of calcium and vitamin D counselling if patient has osteoporosis or on chronic oral corticosteroids (⩾7.5 mg prednisone or equivalent for greater than 3 months) |
| Smoker54 55 59 | Smoking cessation counselling documented or nicotine replacement products/bupropion for discharge if patient is a smoker with history of coronary artery disease, ischaemic stroke, heart failure or type II diabetes |
ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.